Claritas Pharmaceuticals Inc CLAZF

Healthcare Biotechnology

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

GREY:CLAZF - Post by User

Claritas Pharmaceuticals Inc > Covid

<< Previous

Bullboard Posts

Next >>

Comment by SeeDonRunon Sep 18, 2021 12:11am

132 Views

Post# 33882642

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Covid

Sacloco wrote: I use quest trade for most of my trading. Most press releases for these types of stocks are simply marketing ploys to buoy the price and/or slow the downward trend. After the share consolidation the SP soared to $1.20ish, it's been dropping ever since. This was a huge money making opportunity for shorting the stock. The company has zero products, no Chance of any legitimate pharmaceutical company purchasing them or the rights to their research, zero reputation and absolutely nothing to keep the Share price anywhere near $1.20....huge calling card to all the shorters out there. We short the stock which puts massive downward pressure on the SP and voila the SP plummets.... we borrowed the shares at 1.20 and replaced them at .40 cents, we pocket the .80 cent difference....

LOL I can see where that makes sense given the history of this company!

Say, how do you get around the expensive margin rates? Do you actually put up dollar for dollar when you boorow the shares?

<< Previous

Bullboard Posts

Next >>

Cizzle Brands, Changing Consumer Habits in Consumables